CAZZAGON, NORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.654
AS - Asia 1.875
EU - Europa 1.730
SA - Sud America 434
AF - Africa 309
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 17
Totale 10.068
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.469
SG - Singapore 749
IT - Italia 476
HK - Hong Kong 365
CN - Cina 316
BR - Brasile 301
DE - Germania 188
PL - Polonia 132
FI - Finlandia 107
GB - Regno Unito 97
RU - Federazione Russa 91
FR - Francia 85
NL - Olanda 76
SE - Svezia 60
VN - Vietnam 56
AT - Austria 46
TR - Turchia 38
ES - Italia 37
IN - India 37
UA - Ucraina 35
IE - Irlanda 33
JP - Giappone 32
MX - Messico 30
AR - Argentina 25
AU - Australia 25
CI - Costa d'Avorio 20
EC - Ecuador 20
UY - Uruguay 20
CA - Canada 19
IQ - Iraq 19
RS - Serbia 19
ZA - Sudafrica 18
DK - Danimarca 16
EG - Egitto 16
KR - Corea 16
NO - Norvegia 16
RO - Romania 16
CY - Cipro 15
HU - Ungheria 15
BD - Bangladesh 14
BS - Bahamas 14
CH - Svizzera 14
DZ - Algeria 14
EE - Estonia 14
AE - Emirati Arabi Uniti 13
CO - Colombia 13
ID - Indonesia 13
LV - Lettonia 13
PY - Paraguay 13
AF - Afghanistan, Repubblica islamica di 12
BG - Bulgaria 12
TN - Tunisia 12
AZ - Azerbaigian 11
BZ - Belize 11
MK - Macedonia 11
PH - Filippine 11
PK - Pakistan 11
SK - Slovacchia (Repubblica Slovacca) 11
AM - Armenia 10
BA - Bosnia-Erzegovina 10
CZ - Repubblica Ceca 10
ET - Etiopia 10
GR - Grecia 10
GT - Guatemala 10
IL - Israele 10
IS - Islanda 10
LB - Libano 10
MR - Mauritania 10
UZ - Uzbekistan 10
VE - Venezuela 10
BE - Belgio 9
BY - Bielorussia 9
CG - Congo 9
CW - ???statistics.table.value.countryCode.CW??? 9
GF - Guiana Francese 9
JM - Giamaica 9
KE - Kenya 9
MN - Mongolia 9
PA - Panama 9
PE - Perù 9
PS - Palestinian Territory 9
SI - Slovenia 9
TW - Taiwan 9
AD - Andorra 8
BW - Botswana 8
CD - Congo 8
DJ - Gibuti 8
GN - Guinea 8
HN - Honduras 8
MZ - Mozambico 8
NP - Nepal 8
RW - Ruanda 8
TH - Thailandia 8
TZ - Tanzania 8
VC - Saint Vincent e Grenadine 8
XK - ???statistics.table.value.countryCode.XK??? 8
BF - Burkina Faso 7
BJ - Benin 7
BO - Bolivia 7
CV - Capo Verde 7
Totale 9.757
Salva come PNG Salva come JPEG
Città #
Fairfield 919
Ashburn 582
Woodbridge 495
Singapore 447
Houston 400
Chandler 363
Hong Kong 362
Seattle 316
Cambridge 311
Ann Arbor 281
Wilmington 251
Boardman 129
Padova 111
San Diego 111
Beijing 110
Santa Clara 105
Bytom 99
Princeton 77
Medford 76
Jacksonville 63
Munich 63
Des Moines 59
Roxbury 49
Milan 48
Helsinki 36
Rome 34
Nanjing 33
London 31
New York 29
São Paulo 29
Turku 29
Dublin 27
Vienna 24
Los Angeles 23
Nuremberg 23
Hefei 21
Amsterdam 20
Madrid 20
Abidjan 19
Montevideo 19
Ho Chi Minh City 18
Frankfurt am Main 16
Guangzhou 15
Istanbul 15
Melbourne 15
Belgrade 14
Bologna 14
Boston 14
Cairo 14
Tokyo 14
Johannesburg 13
Mexico City 13
Paris 13
Shanghai 13
Stockholm 13
Warsaw 13
Nassau 12
Riga 12
Dallas 11
San Francisco 11
Verona 11
Bucharest 10
Lappeenranta 10
Nicosia 10
Nouakchott 10
Seoul 10
Tianjin 10
Brooklyn 9
Hanoi 9
Oslo 9
Palermo 9
Panama City 9
Reykjavik 9
Shenyang 9
Tallinn 9
Tashkent 9
Baku 8
Cayenne 8
Chicago 8
Conakry 8
Kigali 8
Kingstown 8
Mysiadło 8
Nairobi 8
Redwood City 8
Ulan Bator 8
Zurich 8
Accra 7
Addis Ababa 7
Antananarivo 7
Apia 7
Athens 7
Baghdad 7
Belize City 7
Brasília 7
Buenos Aires 7
Cagliari 7
Dar es Salaam 7
Djibouti 7
Dordives 7
Totale 6.848
Salva come PNG Salva come JPEG
Nome #
UNIGASTRO : Malattie dell' Apparato Digerente . Edizione 2022 - 2025 ( Versione Italiana ) Capitolo: Epatite autoimmune 358
Primary biliary cirrhosis: overlaps with other autoimmune disorders 213
Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis 192
Coronary flow reserve in patients with primary biliary cholangitis 172
Extrahepatic autoimmunity in autoimmune liver disease 171
Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. 170
Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers 168
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 167
Metabolic Syndrome Associated With Primary Biliary Cirrhosis. 163
Extrahepatic Malignancies in Primary Biliary Cirrhosis: A Comparative Study at Two European Centers. 159
The prognostic role of magnetic resonance imaging in Primary Sclerosing Cholangitis 157
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study 149
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. 147
A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. 141
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 140
Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 140
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 139
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 137
Morning bright light treatment for sleep-wake disturbances in primary biliary cholangitis: A pilot study 135
P.16.3 THE PROGNOSTIC ROLE OF MAGNETIC RESONANCE CHOLANGIOGRAPHY IN PSC 132
Diagnostic and Prognostic Role of Scca-IgM Serum Levels in Hepatocellular Carcinoma (Hcc). 132
A novel HER2-targeted liposomal formulation for reducing the risk of liposome-induced hepatotoxicity 132
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres. 127
Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. 126
Molecular targeted therapy in hepatocellular carcinoma: present achievements and future challenges. 125
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 125
Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis. 124
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 123
Retreatment of patients with chronic hepatitis C relapsers to a previous antiviral treatment. 122
New therapies for primary biliary cirrhosis 121
P.1.158: PEG-INTERFERON ALPHA-2A WITH WEIGHT-BASED RIBAVIRIN DOSES IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES: A PILOT STUDY IN A SINGLE CENTRE 120
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis 120
PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 117
New Organ-Specific Drug Strategies Interfering in Signaling Pathways: Kinase Inhibitors and Other New Developmental Drugs in HCC 116
Pregnancy and Primary Biliary Cirrhosis: A Case-Control Study 115
The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis 114
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 114
Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis 113
Incidence and risk factors for extra-hepatic malignancies in primary biliary cirrhosis: A comparative study from two European referral centers 109
Sleep-wake profiles in patients with primary biliary cirrhosis 109
PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 109
Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis 106
Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response. 104
Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitis 101
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 101
INCIDENCE AND RISK FACTORS FOR EXTRA-HEPATIC MALIGNANCIES (EM) IN PRIMARY BILIARY CIRRHOSIS: A COMPARATIVE STUDY FROM TWO EUROPEAN REFERRAL CENTERS 97
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from 20-year multicentre experience in Italy 96
PBC and related extrahepatic diseases 95
A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis 95
Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary prevention. 94
null 93
Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options 92
METABOLIC SYNDROME INDUCES A MORE RAPID PROGRESSION OF FIBROSIS IN PRIMARY BILIARY CIRRHOSIS IN EARLY STAGE 92
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 91
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 91
Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update 91
Pathology of non-alcoholic fatty liver disease 83
In-Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment 83
DIAGNOSTIC AND PROGNOSTIC ROLE OF SCCA-IgM IN HEPATOCELLULAR CARCINOMA (HCC) 83
Primary biliary cholangitis: Perception and expectation of illness in Italian patients 83
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 81
Proposed therapies in primary biliary cholangitis 81
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach 80
Recommendations on the use of magnetic resonance imaging for collaborative multicenter studies in PSC 79
Pathology of autoimmune hepatitis 77
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 73
Gene expression profile in intrahepatic cholestasis of pregnancy. 72
Primary biliary cholangitis: treatment 72
Pregnancy and primary biliary cirrhosis: A case–control study 71
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis 69
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis 69
Letter: the use of magnetic resonance scores (Anali) for risk stratification in PSC 65
Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing Cholangitis 63
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 62
The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs 61
Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis 61
Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis 61
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 60
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 60
Gene expression profile in intrahepatic cholestasis of pregnancy. 58
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis 57
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury 54
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 53
UNIGASTRO: Digestive Diseases. 2022 - 2025 Edition (English Version) Chapter: Autoimmune Hepatitis 53
Primary Sclerosing Cholangitis: Diagnostic Criteria 53
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool 52
Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship 51
Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data 50
Impact on follow-up strategies in patients with primary sclerosing cholangitis 49
Reply to: Correspondence on "EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update" 48
Patient-reported quality of care in primary sclerosing cholangitis 46
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe 44
Liver Immunology, Principles and Practice, Third Edition Chapter 24: Primary Biliary Cholangitis: Autoimmune Hepatitis Overlap Syndrome 43
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 43
The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight 43
Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group 43
Pregnancy and Diseases of the Biliary Tree 40
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis 39
Overlap syndrome 38
Non-contrast MR lymphography of the lymphatic system of the liver 37
Totale 9.945
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.840
article - articoli 36.370
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.799
Totale 77.009
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.005 0 0 168 161 58 33 31 123 122 150 122 37
2021/20221.246 85 82 163 57 69 141 80 96 94 56 87 236
2022/2023895 149 80 13 96 102 153 47 65 102 3 78 7
2023/2024743 25 61 46 54 64 92 123 50 39 35 65 89
2024/20252.605 20 207 101 80 229 85 117 231 276 145 489 625
2025/20261.773 524 724 525 0 0 0 0 0 0 0 0 0
Totale 10.265